C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2002
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/07/2002	WO2002088274A1 Double-spiro organic compounds and electroluminescent devices
11/07/2002	WO2002088128A1 Rational syntheses of heteroleptic lanthanide sandwich coordination complexes
11/07/2002	WO2002088127A2 Triazolopyrimidines
11/07/2002	WO2002088126A1 Triazolopyrimidines
11/07/2002	WO2002088125A2 Triazolopyrimidines having a fungicidal effect
11/07/2002	WO2002088114A2 Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
11/07/2002	WO2002088101A2 Inhibitors of bace
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088078A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
11/07/2002	WO2002087573A1 Crf receptor antagonists
11/07/2002	WO2002087553A2 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
11/07/2002	WO2002087513A2 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	WO2001042243A3 Protein kinase inhibitors
11/07/2002	US20020165401 Use of novel indole compounds for dyeing and making up keratin materials, compositions comprising them and dyeing processes
11/07/2002	US20020165251 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/07/2002	US20020165241 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA)
11/07/2002	US20020165238 Such as 1-(3-carboxypyridyl-2)-4-methyl-2- phenylpiperazine dihydrate; antidepressants
11/07/2002	US20020165216 Controlling oxidation stresses
11/07/2002	US20020165202 Antiinflammatory agents; antiproliferative agents
11/07/2002	US20020165197 Administering adenosine receptor ligand
11/07/2002	US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002	US20020162796 Method of preparing refined organic compound for use in photography with improved liquid-liquid extraction from organic reaction mixture
11/07/2002	DE10121102A1 Triazolopyrimidine Triazolopyrimidines
11/07/2002	DE10119863A1 Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen Use of deoxypeganine for the treatment of psychiatric or cerebral symptoms
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	CA2446497A1 Crf receptor antagonists
11/07/2002	CA2444882A1 Inhibitors of gsk-3 and crystal structures of gsk-3.beta. protein and protein complexes
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/06/2002	EP1254907A1 Pyrrolopyridazine compound
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1253916A1 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/06/2002	EP1196398A4 Bridged fluorescent dyes, their preparation and their use in assays
11/06/2002	EP1104431B1 Metallocenyl phthalocyanines
11/06/2002	EP1030843A4 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	EP0623134B1 Metal complexes of water soluble texaphyrins
11/06/2002	CN1378547A 5-(2-substituted-5-heterocyclylsulphenylpyrid-3-yl)-dihydropyrazolo [4,3-d] pyrimidin 7-ones as phosphodiesterase inhibitors
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1377884A Process for preparing sedenafil
11/06/2002	CN1377881A Intermediate for preparing cascade polymeric ligand and contrast medium
11/06/2002	CN1093859C Novel indole-2,3-dione-3-oxime derivatives
11/06/2002	CN1093767C Protein kinase C inhibitors
11/06/2002	CN1093766C Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization
11/05/2002	US6476236 Synthesis of 2-cyanoaziridine-1-carboxamide
11/05/2002	US6476223 Method for obtaining N-[3(3-cyano-pyrazole[1,5-a]pyrimidine-7-yl)phenyl]-N-ethyl-acetamide
11/05/2002	US6476219 Methods for preparing phthalocyanine compositions
11/05/2002	US6476175 Bicyclic amidines, process for their preparation, and their use as catalyst
11/05/2002	US6476041 1,4 substituted piperidinyl NMDA/NR2B antagonists
11/05/2002	US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002	US6476032 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)one derivatives
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476030 Pyrazolo-triazine derivatives as ligands for GABA receptors
11/05/2002	US6476029 7-alkyl- and cycloalkyl-substituted imidazotriazinones
11/05/2002	US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002	US6476018 Fused imidazole derivatives as multidrug resistance modulators
11/05/2002	CA2205366C Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002085907A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085903A2 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
10/31/2002	WO2002085901A1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
10/31/2002	WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002067654A3 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
10/31/2002	WO2002064574A3 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002	WO2002028874A3 Tumor proliferation inhibitors
10/31/2002	WO2001044243A3 Novel heteroaryl-diazabicycloalkanes
10/31/2002	US20020161231 Intermediate for preparing camptothecin derivatives
10/31/2002	US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/31/2002	US20020161029 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002	US20020161014 Purinyl substituted quinazoline-4-one derivatives
10/31/2002	US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002	US20020160999 Treatment of diseases or disorders of the central nervous system
10/31/2002	US20020160998 Pharmaceutical compositions and methods for use
10/31/2002	US20020160997 Novel indole derivatives
10/31/2002	US20020160963 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
10/31/2002	US20020158242 Containing hexaazatriphenylene based electron transporting material; low drive-voltage; long light emitting life
10/31/2002	DE10121162A1 Triazolopyrimidine Triazolopyrimidines
10/31/2002	DE10121101A1 Triazolopyrimidine Triazolopyrimidines
10/31/2002	CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	CA2444214A1 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
10/31/2002	CA2443556A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
10/31/2002	CA2439960A1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor antagonists)
10/30/2002	EP1253150A1 Polymeric micellar structure
10/30/2002	EP1252164A1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid
10/30/2002	EP1252163A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
10/30/2002	EP1252146A1 Amide compounds for inhibiting protein kinases
10/30/2002	EP1251839A2 Use of cox-2 inhibitors for the treatment of constipation
10/30/2002	EP1105368B1 Photoactivatable bases containing nitrogen
10/30/2002	EP0793660B1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
10/30/2002	EP0662972B1 3-,8-substituted deuteroporphyrine derivatives, pharmaceuticals containing them and methods of producing them
10/30/2002	CN1377358A Novel herbicides

1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 573